Crossmark

Anticancer organorhodium and -iridium complexes with low toxicity <i>in vivo</i> but high potency <i>in vitro</i>: DNA damage, reactive oxygen species formation, and haemolytic activity

Crossref DOI link: https://doi.org/10.1039/C9CC03822A

Published Online: 2019

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Parveen, Shahida

Hanif, Muhammad https://orcid.org/0000-0002-2256-2317
Leung, Euphemia https://orcid.org/0000-0002-6932-3188
Tong, Kelvin K. H. https://orcid.org/0000-0002-3169-0222
Yang, Annie

Astin, Jonathan

De Zoysa, Gayan H. https://orcid.org/0000-0002-5619-468X
Steel, Tasha R.

Goodman, David https://orcid.org/0000-0002-4468-004X
Movassaghi, Sanam

Söhnel, Tilo https://orcid.org/0000-0003-4472-5807
Sarojini, Vijayalekshmi https://orcid.org/0000-0002-5593-8851
Jamieson, Stephen M. F. https://orcid.org/0000-0002-5485-9211
Hartinger, Christian G. https://orcid.org/0000-0001-9806-0893
License Information

Accepted Manuscript valid from 2020-08-30
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

: Crystal Structure Data

IDENTIFIERS

: Muhammad Hanif (ORCID)

: Muhammad Hanif (ResearcherID)

: Euphemia Leung (ORCID)

: Kelvin K. H. Tong (ORCID)

: Gayan H. De Zoysa (ORCID)

: David Goodman (ORCID)

: Tilo Söhnel (ORCID)

: Tilo Söhnel (ResearcherID)

: Vijayalekshmi Sarojini (ORCID)

: Stephen M. F. Jamieson (ORCID)

: Christian G. Hartinger (ORCID)

: Christian G. Hartinger (ResearcherID)

PEER REVIEW METHOD

: Authors can choose between single-blind and double-blind peer review

PUBLICATION HISTORY

: Received 17 May 2019; Accepted 29 August 2019; Accepted Manuscript published 30 August 2019; Advance Article published 9 September 2019; Version of Record published 3 October 2019